Category Archives: ISDS

New trade agreement could ‘expose taxpayers’ to financial risk

By Anna Patty, Brisbane Times Australian taxpayers are being warned they are at risk of picking up the bill if Australia is sued by multinational corporations under a new international trade agreement to be signed this week. Under the Trans … Continue reading

Posted in ISDS, TPP, Uncategorized | Leave a comment

Wrapping Up 2017 – some noteworthy medicines law and policy events.

By  Ellen ‘t Hoen, Medicines Law & Policy | December 31, 2017 2017 was a significant year for access to medicines and other medicines policy related events. Here are a few highlights of the last 12 months. January 2017 kicked off with … Continue reading

Posted in Compulsory Licensing, Data Exclusivity, ISDS, TRIPS, Uncategorized | Leave a comment

The Trans-Pacific Partnership is back: experts respond

Source: The Conversation The latest incarnation of the Trans-Pacific Partnership (TPP) is said to have “fewer bad bits”. But as our experts point out below, there’s still a great deal wrong with, or missing from, the regional free trade agreement. The new … Continue reading

Posted in ISDS, TPP, Uncategorized | Leave a comment

Govt will lose gold mine dispute due to Article 44 use: academics

Govt will lose gold mine dispute due to Article 44 use: academics By PRATCH RUJIVANAROM The Nation (Thailand) | 1 Sep 2017 BANGKOK: — Experts and academics have warned that Thailand will lose an arbitral tribunal process regarding allegations that it … Continue reading

Posted in BITS, ISDS, Uncategorized | Tagged | Leave a comment

Company sues Ukraine in bid to corner hepatitis C drug market

By Josh Kovensky, KyivPost | June 16, 2017 A doctor checks a patient for Hepatitis C in Zaporizhiya. As much as 10 percent of the Ukrainian population could be infected with the disease. Photo by UNIAN Multinational pharmaceutical firm Gilead Sciences has … Continue reading

Posted in Data Exclusivity, ISDS, Uncategorized | 2 Comments

Government should release Philip Morris plain packaging case costs says Fair Trade group

Media Release | July 10, 2017 “We welcome the international tribunal decision that Philip Morris tobacco company should pay the costs of its failed case against Australia’s 2011 plain packaging law. But it is absurd and unacceptable that the tribunal has … Continue reading

Posted in BITS, Investment treaties, ISDS, Uncategorized | Leave a comment

Lexmark: The Supreme Court’s patent exhaustion case and parallel trade in drugs

Source: Knowledge Ecology International The Supreme Court’s decision in IMPRESSION PRODUCTS, INC. v. LEXMARK INTERNATIONAL, INC.  has clarified that the United States has world wide exhaustion of patent rights.   According to Professor Fred Abbott, who knows a lot about this issue, and … Continue reading

Posted in Cancer, Delinkage, ISDS, R&D, Uncategorized, USFDA | Leave a comment